Mark J Gergen insider trades: Poseida Therapeutics (PSTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | PSTX | ↓ Sell | 30,000 | $9.46 | $284K | Direct | Dec 11, 2024 (1d) |
| Nov 26, 2024 | PSTX | ↓ Sell | 30,000 | $9.27 | $278K | Direct | Nov 27, 2024 (1d) |
| Jan 15, 2016 | MRTX | ↓ Sell | 10,000 | $25.92 | $259K | Direct | Jan 19, 2016 (4d) |
| Mar 1, 2012 | AMLN | ↓ Sell | 1,846 | $17.11 | $32K | Direct | Mar 2, 2012 (1d) |
| Feb 23, 2012 | AMLN | ↓ Sell | 7,518 | $17.03 | $128K | Direct | Feb 24, 2012 (1d) |
| Nov 1, 2007 | AMLN | ↓ Sell | 500 | $44.00 | $22K | Direct | Nov 2, 2007 (1d) |
| Oct 3, 2007 | AMLN | ↓ Sell | 500 | $50.00 | $25K | Direct | Oct 4, 2007 (1d) |
| Oct 1, 2007 | AMLN | ↓ Sell | 500 | $49.83 | $25K | Direct | Oct 2, 2007 (1d) |
| Sep 4, 2007 | AMLN | ↓ Sell | 1,000 | $49.50 | $50K | Direct | Sep 6, 2007 (2d) |
| Aug 7, 2007 | AMLN | ↓ Sell | 500 | $50.00 | $25K | Direct | Aug 8, 2007 (1d) |
| Aug 1, 2007 | AMLN | ↓ Sell | 500 | $46.50 | $23K | Direct | Aug 2, 2007 (1d) |
| Jul 24, 2007 | AMLN | ↓ Sell | 500 | $45.00 | $23K | Direct | Jul 25, 2007 (1d) |
| Jul 2, 2007 | AMLN | ↓ Sell | 500 | $41.20 | $21K | Direct | Jul 3, 2007 (1d) |
| Jun 1, 2007 | AMLN | ↓ Sell | 1,000 | $46.16 | $46K | Direct | Jun 4, 2007 (3d) |
| May 21, 2007 | AMLN | ↓ Sell | 500 | $45.00 | $23K | Direct | May 23, 2007 (2d) |
| May 1, 2007 | AMLN | ↓ Sell | 500 | $41.25 | $21K | Direct | May 2, 2007 (1d) |
| Apr 2, 2007 | AMLN | ↓ Sell | 500 | $37.47 | $19K | Direct | Apr 3, 2007 (1d) |
| Mar 1, 2007 | AMLN | ↓ Sell | 500 | $37.75 | $19K | Direct | Mar 2, 2007 (1d) |
| Feb 1, 2007 | AMLN | ↓ Sell | 500 | $38.75 | $19K | Direct | Feb 2, 2007 (1d) |
| Jan 3, 2007 | AMLN | ↓ Sell | 500 | $36.29 | $18K | Direct | Jan 4, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark J Gergen's insider trades
Mark J Gergen is President and CEO at Poseida Therapeutics (PSTX). Since Jan 3, 2007, Mark has reported no open-market purchases and 20 sales worth $1.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (25 filings), option exercises (18 filings), shares withheld for taxes (5 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PSTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.